Label: DG HEALTH SLEEP AID- doxylamine succinate tablet

  • NDC Code(s): 55910-909-53, 55910-909-62
  • Packager: Dolgencorp Inc
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated March 5, 2025

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Doxylamine succinate 25 mg

  • Purpose

    Nighttime sleep-aid

  • Use

    •
    helps to reduce difficulty in falling asleep
  • Warnings

    Do not use

    •
    in children under 12 years of age
    •
    with any other product containing doxylamine
    •
    unless you have time for a full night’s sleep

    Ask a doctor before use if you have

    •
    a breathing problem such as emphysema or chronic bronchitis
    •
    glaucoma
    •
    trouble urinating due to an enlarged prostate gland

    Ask a doctor or pharmacist before use if you are

    taking

    •
    a sedative or any other sleep-aid
    •
    tranquilizers
    •
    any other antihistamines
    •
    any other drugs

    When using this product

    •
    avoid alcoholic beverages
    •
    do not drive a motor vehicle or operate machinery
    •
    take only at bedtime

    Stop use and ask a doctor if

    •
    sleeplessness persists continuously for more than two weeks. Insomnia may be a symptom of serious underlying medical illness.

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    •
    adults and children 12 years of age and over: take one tablet 30 minutes before going to bed; take once daily or as directed by a doctor
    •
    children under 12 years of age: do not use
  • Other information

    •
    store at 20-25°C (68-77°F)
    •
    keep carton. It contains important information.
  • Inactive ingredients

    anhydrous dibasic calcium phosphate, dibasic calcium phosphate dihydrate, FD&C blue no. 1 aluminum lake, magnesium stearate, microcrystalline cellulose, sodium starch glycolate

  • Questions or comments?

    1-888-309-9030

  • Package/Label Principal Display Panel

    DG™ | health

    Compare to the active ingredient of Vicks® ZzzQuil® Ultra

    Ultra

    Sleep Aid

    Doxylamine Succinate Tablets, 25 mg

    Nighttime Sleep-Aid

    Clinically Tested, Proven Effective

    25 mg

    24 Tablets

    Actual Tablet Size

    1 Tablet Per Dose

    sleep-aid-carton-image-1
    sleep-aid-carton-image-2
  • INGREDIENTS AND APPEARANCE
    DG HEALTH SLEEP AID 
    doxylamine succinate tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55910-909
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DOXYLAMINE SUCCINATE (UNII: V9BI9B5YI2) (DOXYLAMINE - UNII:95QB77JKPL) DOXYLAMINE SUCCINATE25 mg
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
    FD&C BLUE NO. 1 ALUMINUM LAKE (UNII: J9EQA3S2JM)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)  
    Product Characteristics
    ColorBLUEScore2 pieces
    ShapeOVALSize10mm
    FlavorImprint Code L441
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:55910-909-5312 in 1 CARTON05/23/2023
    11 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:55910-909-6224 in 1 CARTON05/17/2023
    21 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA04016705/17/2023
    Labeler - Dolgencorp Inc (068331990)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!